Pharmaceuticals

A congenital connective tissue disorder that confers pro basketball height also permanently benches an NBA prospect’s dreams of joining the league

A lab director has reportedly been reassigned and other heads at the U.S. Center for Disease Control are likely to roll after an incident earlier this month in which at least 75 staff members may have accidentally been exposed to live samples of anthrax being transported from one lab to another.

My PhD mostly dealt with research blogs from ResearchBlogging.org (RB) an aggregator of blog posts covering peer-reviewed research. In this article, we (Prof.

New global clinical trial aims to replicate the mysterious “Mississippi baby” success

The use of viruses that kill bacteria as a tool for treating infections are under study again by Western researchers and governments

Alexander Shulgin, chemist and renowned psychonaut who acquainted the world with the drug MDMA - or Ecstasy - died Monday evening at his home in Lafayette, Calif.

Alexander Shulgin, the most prolific psychedelic chemist in history, has died at the age of 88. I interviewed Shulgin and his wife and co-researcher Ann at their home in California in 1999, when I was researching my 2003 book Rational Mysticism.

Compared with 50 years ago, today's heroin user is whiter, more suburban and had prescription opioids for a gateway. Dina Fine Maron reports
 

Desperate to develop new drugs for malaria and other ailments, researchers are running clinical trials with traditional herbal medicines—and generating promising leads

Drug companies have begun to share their clinical trial data. The long-overdue shift heralds a new era in medicine

And a new diabetes drug targets those sweet receptors

The Resilience Project seeks to find people who are unaffected by genetic mutations that would normally cause severe and fatal disorders